<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03767166</url>
  </required_header>
  <id_info>
    <org_study_id>2275</org_study_id>
    <nct_id>NCT03767166</nct_id>
  </id_info>
  <brief_title>The Archimedes Biodegradable Biliary and Pancreatic Stents</brief_title>
  <acronym>ARCHIMEDES</acronym>
  <official_title>A Prospective, Single Arm Study to Evaluate the Feasibility of the Archimedes Biodegradable Biliary and Pancreatic Stents Placement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Clinico Humanitas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Clinico Humanitas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, phase II, single-centre, non-randomised, single-arm study, enrolling
      patients with benign and malignant bilio-pancreatic diseases with an indication to biliary or
      pancreatic plastic stent positioning during ERCP.

      On procedure day, the study team will confirm that the patient meets all the inclusion
      criteria and none of the exclusion criteria.

      The patient will undergo the ABS insertion and monitored and follow-up accordingly to
      biodegration variant.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Biodegradation time</measure>
    <time_frame>24 Months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pancreatic Diseases</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biodegradable biliary and pancreatic stents placement</intervention_name>
    <description>Biodegradable biliary and pancreatic stents placement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with benign and malignant bilio-pancreatic diseases with an indication to biliary
        or pancreatic plastic stent positioning during ERCP.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with an indication to position one ore more biliary plastic stents during
             ERCP

          -  Patients with an indication to position a pancreatic plastic stent during ERCP

        Exclusion Criteria:

          -  Age &lt; 18 y

          -  Life expectancy &lt; 1 m,

          -  Inability to pass a guidewire through stricture

          -  Contra-indication for endoscopy or interventional radiology

          -  Presence of partial gastric resection

          -  Unsigned informing consent form, ICF

          -  Pregnancy

          -  Pseudo Klatskin tumors (metastases in the liver hilum) and gallbladder carcinoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Alessandro Repici, MD</last_name>
    <phone>0039-02-82247493</phone>
    <email>alessandro.repici@hunimed.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrea Anderloni, MD</last_name>
    <phone>0039-02-82247308</phone>
    <email>andrea.anderloni@humanitas.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Endoscopy Unit, Humanitas Research Hospital</name>
      <address>
        <city>Rozzano</city>
        <state>Milano</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Repici, MD</last_name>
      <phone>+39282247493</phone>
      <email>alessandro.repici@humanitas.it</email>
    </contact>
    <investigator>
      <last_name>Alessandro Repici, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Carrara, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Anderloni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milena Di Leo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 20, 2018</study_first_submitted>
  <study_first_submitted_qc>December 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2018</study_first_posted>
  <last_update_submitted>November 8, 2019</last_update_submitted>
  <last_update_submitted_qc>November 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

